Status:
RECRUITING
PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Severe Infection
Eligibility:
All Genders
Brief Summary
PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infect...
Eligibility Criteria
Inclusion
- Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033
- PHAGEinLYON Clinic cohort study information notice provided to the patient
Exclusion
- Opposition of trial participant
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2034
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06185920
Start Date
February 1 2023
End Date
February 1 2034
Last Update
December 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Infectious and Tropical Diseases of the Croix Rousse Hospital of the Civil Hospitals of Lyon
Lyon, France, 69004